Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes that go beyond their initial indication for lowering blood sugar levels. In clinical trials, ...
Nov 2, 2023
0
1